Found: 29
Select item for more details and to access through your institution.
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation.
- Published in:
- Nature Communications, 2023, v. 14, p. 1, doi. 10.1038/s41467-022-35222-4
- By:
- Publication type:
- Article
Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 1831, doi. 10.3390/ijms20081831
- By:
- Publication type:
- Article
STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 6, p. 1803, doi. 10.3390/ijms19061803
- By:
- Publication type:
- Article
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 7, p. 2977, doi. 10.1172/JCI73174
- By:
- Publication type:
- Article
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
- Published in:
- Glia, 2009, v. 57, n. 13, p. 1458, doi. 10.1002/glia.20863
- By:
- Publication type:
- Article
Cutting-edge advances in modeling the blood–brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brain.
- Published in:
- Cell & Bioscience, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13578-023-01079-3
- By:
- Publication type:
- Article
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 10, p. 925, doi. 10.1038/nbt.1564
- By:
- Publication type:
- Article
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.
- Published in:
- Nature Medicine, 2010, v. 16, n. 12, p. 1421, doi. 10.1038/nm.2250
- By:
- Publication type:
- Article
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.
- Published in:
- Nature Medicine, 2005, v. 11, n. 12, p. 1314, doi. 10.1038/nm1325
- By:
- Publication type:
- Article
Corrigendum: Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.
- Published in:
- 2004
- By:
- Publication type:
- Correction Notice
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.
- Published in:
- Nature Medicine, 2004, v. 10, n. 1, p. 48, doi. 10.1038/nm976
- By:
- Publication type:
- Article
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 979, doi. 10.1007/s00262-017-1966-2
- By:
- Publication type:
- Article
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.
- Published in:
- Oncogene, 2005, v. 24, n. 36, p. 5552, doi. 10.1038/sj.onc.1208719
- By:
- Publication type:
- Article
Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2426, doi. 10.3390/cancers13102426
- By:
- Publication type:
- Article
MEETING HIGHLIGHTS: THE THIRD MARIE SKŁODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023.
- Published in:
- Wiadomości Lekarskie, 2023, v. 76, n. 12, p. 2543, doi. 10.36740/WLek202312101
- By:
- Publication type:
- Article
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.
- Published in:
- Nature Reviews Immunology, 2007, v. 7, n. 1, p. 41, doi. 10.1038/nri1995
- By:
- Publication type:
- Article
How to Train Your Dragon: Targeted Delivery of MicroRNA to Cancer Cells In Vivo.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 6, p. 1070, doi. 10.1038/mt.2014.73
- By:
- Publication type:
- Article
Targeting STAT3 in tumora-ssociated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1274781
- By:
- Publication type:
- Article
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
- Published in:
- Oncogene, 1999, v. 18, n. 25, p. 3742, doi. 10.1038/sj.onc.1202708
- By:
- Publication type:
- Article
Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Beclin-1 as a neutrophil-specific immune checkpoint.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Editorial: Roles of Tumor-Recruited Myeloid Cells in Immune Evasion in Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Interferon-γ-Mediated Growth Regulation of Melanoma Cells: Involvement of STAT1-Dependent and STAT1-Independent Signals.
- Published in:
- Journal of Investigative Dermatology, 2004, v. 122, n. 2, p. 414, doi. 10.1046/j.0022-202X.2004.22237.x
- By:
- Publication type:
- Article
Interleukin-6-Resistant Melanoma Cells Exhibit Reduced Activation of STAT3 and Lack of Inhibition of Cyclin E-Associated Kinase Activity.
- Published in:
- Journal of Investigative Dermatology, 2001, v. 117, n. 1, p. 132, doi. 10.1046/j.0022-202X.2001.01372.x
- By:
- Publication type:
- Article
SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 6, p. 1, doi. 10.1038/s41419-018-0693-8
- By:
- Publication type:
- Article
TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
- Published in:
- Journal of Leukocyte Biology, 2017, v. 102, n. 2, p. 423, doi. 10.1189/jlb.3MA1016-451RR
- By:
- Publication type:
- Article
Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep05750
- By:
- Publication type:
- Article
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).
- Published in:
- 2018
- By:
- Publication type:
- journal article